These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 28751674)

  • 41. The anti-inflammatory effect of ε-viniferin by specifically targeting formyl peptide receptor 1 on human neutrophils.
    Liao HR; Lin CH; Chen JJ; Liu FC; Tseng CP
    Chem Biol Interact; 2021 Aug; 345():109490. PubMed ID: 34144024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The potential impacts of formyl peptide receptor 1 in inflammatory diseases.
    Yang SC; Hwang TL
    Front Biosci (Elite Ed); 2016 Jun; 8(3):436-49. PubMed ID: 27100350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.
    Kirpotina LN; Khlebnikov AI; Schepetkin IA; Ye RD; Rabiet MJ; Jutila MA; Quinn MT
    Mol Pharmacol; 2010 Feb; 77(2):159-70. PubMed ID: 19903830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potent inhibition of superoxide anion production in activated human neutrophils by isopedicin, a bioactive component of the Chinese medicinal herb Fissistigma oldhamii.
    Hwang TL; Li GL; Lan YH; Chia YC; Hsieh PW; Wu YH; Wu YC
    Free Radic Biol Med; 2009 Feb; 46(4):520-8. PubMed ID: 19100830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
    Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S
    Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formyl peptide receptor 1 up-regulation and formyl peptide receptor 2/3 down-regulation of blood immune cells along with defective lipoxin A4/resolvin D1 production in obstructive sleep apnea patients.
    Chen YC; Su MC; Chin CH; Lin IC; Hsu PY; Liou CW; Huang KT; Wang TY; Lin YY; Zheng YX; Hsiao CC; Lin MC
    PLoS One; 2019; 14(5):e0216607. PubMed ID: 31116781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Cheng N; Ye RD; Quinn MT
    Biochem Pharmacol; 2014 Dec; 92(4):627-41. PubMed ID: 25450672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production.
    Liou KT; Shen YC; Chen CF; Tsao CM; Tsai SK
    Eur J Pharmacol; 2003 Aug; 475(1-3):19-27. PubMed ID: 12954355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling.
    Bae YS; Lee HY; Jo EJ; Kim JI; Kang HK; Ye RD; Kwak JY; Ryu SH
    J Immunol; 2004 Jul; 173(1):607-14. PubMed ID: 15210823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop.
    Forsman H; Bylund J; Oprea TI; Karlsson A; Boulay F; Rabiet MJ; Dahlgren C
    Biochim Biophys Acta; 2013 Aug; 1833(8):1914-23. PubMed ID: 23562731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria.
    Dahlgren C; Gabl M; Holdfeldt A; Winther M; Forsman H
    Biochem Pharmacol; 2016 Aug; 114():22-39. PubMed ID: 27131862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel antimicrobial peptide isolated from centipede Scolopendra subspinipes mutilans stimulates neutrophil activity through formyl peptide receptor 2.
    Park YJ; Kim HS; Lee HY; Hwang JS; Bae YS
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):352-357. PubMed ID: 28988115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells.
    Ou HC; Chou FP; Lin TM; Yang CH; Sheu WH
    Chem Biol Interact; 2006 May; 161(1):1-13. PubMed ID: 16580656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exogenous carbon monoxide inhibits neutrophil infiltration in LPS-induced sepsis by interfering with FPR1 via p38 MAPK but not GRK2.
    Wang X; Qin W; Song M; Zhang Y; Sun B
    Oncotarget; 2016 Jun; 7(23):34250-65. PubMed ID: 27144520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Residues Critical for FPR2 Activation by the Cryptic Peptide Mitocryptide-2 Originating from the Mitochondrial DNA-Encoded Cytochrome
    Lind S; Gabl M; Holdfeldt A; Mårtensson J; Sundqvist M; Nishino K; Dahlgren C; Mukai H; Forsman H
    J Immunol; 2019 May; 202(9):2710-2719. PubMed ID: 30902901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FITC Conjugation Markedly Enhances Hepatic Clearance of N-Formyl Peptides.
    Øie CI; Snapkov I; Elvevold K; Sveinbjørnsson B; Smedsrød B
    PLoS One; 2016; 11(8):e0160602. PubMed ID: 27494406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands.
    He HQ; Troksa EL; Caltabiano G; Pardo L; Ye RD
    J Biol Chem; 2014 Jan; 289(4):2295-306. PubMed ID: 24285541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-inflammatory bioactivities of honokiol through inhibition of protein kinase C, mitogen-activated protein kinase, and the NF-kappaB pathway to reduce LPS-induced TNFalpha and NO expression.
    Chao LK; Liao PC; Ho CL; Wang EI; Chuang CC; Chiu HW; Hung LB; Hua KF
    J Agric Food Chem; 2010 Mar; 58(6):3472-8. PubMed ID: 20192217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Membrane lipid microdomains differentially regulate intracellular signaling events in human neutrophils.
    Tuluc F; Meshki J; Kunapuli SP
    Int Immunopharmacol; 2003 Dec; 3(13-14):1775-90. PubMed ID: 14636828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.
    Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
    Int Immunopharmacol; 2016 Aug; 37():43-58. PubMed ID: 26382576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.